| Financial Year |
March 31 2023 |
| Monetary Funds |
3,128,615,723.59 |
| Held-for-trading Financial Assets |
30,387,360.07 |
| Notes Receivable |
176,410,474.00 |
| Accounts Receivable |
2,055,685,869.79 |
| Advances to Suppliers |
262,112,895.24 |
| Other Receivables |
128,077,484.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
172,931.51 |
| Dividend Receivable |
-- |
| Inventories |
1,948,994,337.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
215,204,057.24 |
| Other Current Assets |
182,712,155.24 |
| Total Current Assets |
8,315,328,866.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
73,326,585.31 |
| Long-term Equity Investment |
2,267,078,336.66 |
| Investment Properties |
428,891,698.16 |
| Fixed Assetes |
1,366,110,717.18 |
| Under-construction Projects |
389,573,434.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
372,023,670.19 |
| R&D expenses |
-- |
| Goodwill |
1,199,827,169.04 |
| Long-Term Deferred and Prepaid Expenses |
253,515,593.75 |
| Deferred Income Tax Assets |
201,463,020.37 |
| Other Non-Current Assets |
182,371,574.36 |
| Sub-Total of Non-Current Assets |
7,968,613,377.33 |
| Total Assets |
16,283,942,244.29 |
| Short-Term Loans |
420,828,370.06 |
| Trading Financial liabilities |
16,874,400.88 |
| Notes Payable |
668,596,128.85 |
| Accounts Payable |
1,832,582,110.46 |
| Accounts Received In Advance |
10,125,191.64 |
| Employee Compensation Payable |
390,614,710.59 |
| Taxes Payable |
147,851,878.20 |
| Interest Payable |
-- |
| Dividend Payable |
13,319,326.20 |
| Other payables |
1,324,821,063.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
175,446,787.49 |
| Other Current Liabilities |
92,485,817.44 |
| Sub-Total of Current Liabilities |
5,399,830,680.63 |
| Long-term Loans |
150,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
97,994,628.14 |
| Deferred Income Tax Liabilities |
100,197,890.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
952,055,867.31 |
| Total Liabilities |
6,351,886,547.94 |
| Paid-In Capital(Or Share Stock) |
1,412,651,571.00 |
| Capital Surplus |
3,428,491,098.85 |
| Surplus Reserve |
430,399,741.59 |
| LESS:Treasury Stock |
189,483,979.52 |
| Undistributed Profits |
4,645,920,087.04 |
| Minority Stockholder's Interest |
144,859,568.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,787,196,127.43 |
| Owner's Equity（Stockholder's Equity） |
9,932,055,696.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,283,942,244.29 |
